Lawrence Guiheen
Director/Board Member chez ADMA BIOLOGICS, INC.
Fortune : 676 754 $ au 30/04/2024
Profil
Lawrence P.
Guiheen is an Independent Non-Executive Director at ADMA Biologics, Inc. since 2012.
He is also a Director at Kedrion Biopharma, Inc. since 2013.
Previously, he served as the Chief Executive Officer at Wellmond Therapeutics from 2019 to 2022.
He was also the Chairman at Plasma Protein Therapeutics Association and a Director at California Healthcare Institute.
Mr. Guiheen worked as the General Manager-Global Hemophilia Franchise at Baxter Healthcare Corp.
from 2010 to 2011.
He was the President-BioPharmaceuticals at Baxter BioScience Corp.
from 2010 to 2011.
Additionally, he held the position of Executive Vice President at Wellstat Management Co. LLC from 2019 to 2022.
Mr. Guiheen was the Principal at Guiheen & Associates LLC from 2011 to 2013.
He completed his undergraduate degree at Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADMA BIOLOGICS, INC.
0,05% | 26/02/2024 | 105 086 ( 0,05% ) | 676 754 $ | 30/04/2024 |
Postes actifs de Lawrence Guiheen
| Sociétés | Poste | Début |
|---|---|---|
| ADMA BIOLOGICS, INC. | Director/Board Member | 24/07/2012 |
Kedrion Biopharma, Inc.
 Kedrion Biopharma, Inc. Medical/Nursing ServicesHealth Services Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ. | Director/Board Member | 01/11/2019 |
Anciens postes connus de Lawrence Guiheen
| Sociétés | Poste | Fin |
|---|---|---|
| Wellmond Therapeutics | Chief Executive Officer | 01/02/2022 |
Wellstat Management Co. LLC
 Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 01/02/2022 |
| Guiheen & Associates LLC | Corporate Officer/Principal | 01/07/2013 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | - |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/07/2011 |
Formation de Lawrence Guiheen
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADMA BIOLOGICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
| California Healthcare Institute | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
Wellstat Management Co. LLC
Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Commercial Services |
| Guiheen & Associates LLC | |
Kedrion Biopharma, Inc.
Kedrion Biopharma, Inc. Medical/Nursing ServicesHealth Services Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ. | Health Services |
| Wellmond Therapeutics |
